Bank of New York Mellon’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,289
| Closed | -$283K | – | 4191 |
|
|
2025
Q1 | $283K | Hold |
26,289
| – | – | ﹤0.01% | 3711 |
|
|
2024
Q4 | $337K | Hold |
26,289
| – | – | ﹤0.01% | 3694 |
|
|
2024
Q3 | $726K | Sell |
26,289
-7,309
| -22% | -$202K | ﹤0.01% | 3303 |
|
|
2024
Q2 | $974K | Buy |
33,598
+1,924
| +6% | +$55.8K | ﹤0.01% | 3215 |
|
|
2024
Q1 | $1.41M | Sell |
31,674
-1,377
| -4% | -$61.4K | ﹤0.01% | 2957 |
|
|
2023
Q4 | $1.28M | Sell |
33,051
-27
| -0.1% | -$1.05K | ﹤0.01% | 3061 |
|
|
2023
Q3 | $972K | Buy |
33,078
+118
| +0.4% | +$3.47K | ﹤0.01% | 3164 |
|
|
2023
Q2 | $2.1M | Buy |
32,960
+263
| +0.8% | +$16.7K | ﹤0.01% | 2801 |
|
|
2023
Q1 | $1.54M | Sell |
32,697
-114
| -0.3% | -$5.38K | ﹤0.01% | 2940 |
|
|
2022
Q4 | $2.28M | Sell |
32,811
-127
| -0.4% | -$8.81K | ﹤0.01% | 2789 |
|
|
2022
Q3 | $4.83M | Buy |
32,938
+5,475
| +20% | +$803K | ﹤0.01% | 2312 |
|
|
2022
Q2 | $3.58M | Buy |
27,463
+7,955
| +41% | +$1.04M | ﹤0.01% | 2496 |
|
|
2022
Q1 | $1.97M | Buy |
19,508
+15,944
| +447% | +$1.61M | ﹤0.01% | 2950 |
|
|
2021
Q4 | $552K | Buy |
3,564
+633
| +22% | +$98K | ﹤0.01% | 3740 |
|
|
2021
Q3 | $867K | Buy |
+2,931
| New | +$867K | ﹤0.01% | 3468 |
|